The BPC opinion on the application for approval of the active substances benzalkonium chloride (BKC) and didecyl-dimethylammonium chloride (DDAC) in both PT1 and PT2 were adopted in December 2021.
PT1 and PT2 approval BKC and DDAC
The BPC opinion on the application for approval of the active substances benzalkonium chloride (BKC – CAS 68424-85-1) and didecyldimethylammonium chloride (DDAC – CAS 7173-51-5) in both PT1 and PT2 were adopted in December 2021. This means that the estimated BPR submission deadline for PT1 and PT2 biocidal products containing these active substances is December 2023. Now is the time to act and prepare your BPR dossier(s)! See our flyer for a more elaborate timeline.
The implementation of the latest guidance on Biocidal Product Family concept (CA-July19-Doc.4.2 – Guidance note on BPF concept) in different pre-consortia indicated several challenges to group multiple products and uses. After careful consideration, some companies have decided to proceed with an individual dossier(s).